Growth Metrics

PAVmed (PAVM) Acquisitions (2021 - 2022)

PAVmed's quarterly Acquisitions came in at $1.0 million in Q3 2022, up 900.0% year-on-year from $100000.0 in Q3 2021, and down 52.38% quarter-over-quarter from $2.1 million in Q4 2021.

PAVmed has reported Acquisitions for 2 years, with the latest figure at $1.0 million in Q3 2022.

  • For the quarter ending Q3 2022, Acquisitions rose 900.0% year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2022 stood at $3.2 million (changed N/A YoY), and the FY2022 full-year result was $3.2 million, up 42.41% from the prior year.
  • Acquisitions for Q3 2022 stood at $1.0 million, down from $2.1 million in the prior quarter.
  • The five-year high for Acquisitions was $2.1 million in Q4 2021, with the low at $100000.0 in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 PAVmed 4.15 Mn -9.02 Mn -703,000.00 -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2022 1.00 Mn
Dec 31, 2021 2.10 Mn
Sep 30, 2021 100,000.00